Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Online Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers

Start: January 1, 2021
End: January 2024
Enrollment: 60

What Is This Study About?

Cognitive behavioral therapy for insomnia (CBT-I) is an established treatment for insomnia in adults. This pilot study, named NiteCAPP,  will test whether a web-based CBT-I program can reduce insomnia in dementia caregivers. Caregivers will participate in four online CBT sessions on healthy sleep habits and relaxation strategies and will complete a daily electronic sleep diary. Researchers will evaluate sleep quality, as well as levels of anxiety, pain, depression, cognition, caregiver stress, and quality of life.

Do I Qualify To Participate in This Study?

Minimum Age: 18 Years

Maximum Age: N/A

Must have:

  • Dementia caregiver living with a person with dementia
  • Read and understand English
  • If currently taking prescribed or over-the-counter sleep medications, dosage must be stable for at least six weeks before study screening visit
  • Meets criteria for insomnia diagnosis, including:
    • Symptoms of sleep loss (e.g., fatigue) for more than six months
    • Adequate opportunity and circumstances for sleep
    • One or more of the following: difficulty falling asleep, staying asleep, or waking too early
    • Daytime disruption due to insomnia (e.g., mood, cognition, social relationships, work performance) 
  • Insomnia Severity Index score of 9 to 11
  • Time to fall asleep >30 minutes or becoming awake after falling asleep, on three or more nights a week

Must NOT have:

  • Cognitive impairment
  • Sleep disorder other than insomnia (e.g., sleep apnea)
  • Bipolar or seizure disorder
  • Major psychopathology (e.g., suicide ideation/intent, psychosis) or severe, untreated psychiatric condition; depression and anxiety acceptable
  • Psychotropic or other medications (e.g., beta-blockers) that affect sleep
  • Nonpharmacological treatments for sleep or mood outside of current study

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Study Contact
Christina S McCrae
Riley Stephens

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Missouri
University of Missouri
Columbia, MO 65212
Recruiting
Christina McCrae

Who Sponsors This Study?

Lead: University of Missouri-Columbia

Source: ClinicalTrials.gov ID: NCT04632628

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health